-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$40.5035.23% Upside
Collegium Pharmaceutical, Inc. Frequently Asked Questions
-
What analysts cover Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. has been rated by research analysts at Jefferies, H.C. Wainwright, Piper Sandler, Needham in the past 90 days.